Investigational Drug Information for Atamestane
✉ Email this page to a colleague
What is the development status for investigational drug Atamestane?
Atamestane is an investigational drug.
There have been 4 clinical trials for Atamestane.
The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2005.
The most common disease conditions in clinical trials are Breast Neoplasms, Neoplasms, Hormone-Dependent, and Neoplasms. The leading clinical trial sponsors are Intarcia Therapeutics and [disabled in preview].
Summary for Atamestane
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 5,765 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 266 |
| Clinical Trial Progress | Phase 3 (2005-11-01) |
| Vendors | 14 |
Recent Clinical Trials for Atamestane
| Title | Sponsor | Phase |
|---|---|---|
| Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer | Intarcia Therapeutics | Phase 3 |
| The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer | Intarcia Therapeutics | Phase 3 |
| Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer | Intarcia Therapeutics | Phase 3 |
Clinical Trial Summary for Atamestane
Top disease conditions for Atamestane
Top clinical trial sponsors for Atamestane
US Patents for Atamestane
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
